Victory Capital Management Inc Inovio Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.38 - $0.58 $364 - $555	958 Added 3.43%	28,871 $11,000
Q2 2023 Jul 27, 2023	SELL	$0.39 - $0.94 $253 - $611	-650 Reduced 2.28%	27,913 $12,000
Q1 2023 May 02, 2023	BUY	$0.79 - $1.91 $650 - $1,573	824 Added 2.97%	28,563 $23,000
Q4 2022 Feb 09, 2023	SELL	$1.41 - $2.5 $18 - $32	-13 Reduced 0.05%	27,739 $43,000
Q3 2022 Nov 02, 2022	SELL	$1.66 - $2.79 $3,603 - $6,057	-2,171 Reduced 7.26%	27,752 $48,000
Q2 2022 Aug 01, 2022	BUY	$1.44 - $3.98 $3,245 - $8,970	2,254 Added 8.15%	29,923 $52,000
Q1 2022 May 04, 2022	SELL	$2.97 - $5.2 $2,346 - $4,108	-790 Reduced 2.78%	27,669 $76,000
Q4 2021 Feb 07, 2022	SELL	$4.99 - $7.46 $4,421 - $6,609	-886 Reduced 3.02%	28,459 $142,000
Q3 2021 Nov 02, 2021	SELL	$7.16 - $9.69 $8,455 - $11,443	-1,181 Reduced 3.87%	29,345 $210,000
Q2 2021 Aug 03, 2021	SELL	$6.23 - $10.03 $7,370 - $11,865	-1,183 Reduced 3.73%	30,526 $283,000
Q1 2021 May 04, 2021	SELL	$8.81 - $16.96 $68,841 - $132,525	-7,814 Reduced 19.77%	31,709 $294,000
Q4 2020 Feb 01, 2021	SELL	$8.5 - $12.85 $75,650 - $114,365	-8,900 Reduced 18.38%	39,523 $350,000
Q3 2020 Nov 09, 2020	BUY	$9.57 - $27.05 $117,471 - $332,038	12,275 Added 33.96%	48,423 $562,000
Q2 2020 Aug 07, 2020	BUY	$7.14 - $31.69 $97,625 - $433,297	13,673 Added 60.84%	36,148 $974,000
Q1 2020 May 04, 2020	SELL	$2.98 - $14.09 $43,728 - $206,756	-14,674 Reduced 39.5%	22,475 $167,000
Q4 2019 Feb 06, 2020	BUY	$1.97 - $3.72 $40,717 - $76,888	20,669 Added 125.42%	37,149 $123,000
Q4 2019 Feb 04, 2020	BUY	$1.97 - $3.72 $126 - $238	64 Added 0.39%	16,480 $75,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $3.02 $33,652 - $49,576	16,416 New	16,416 $34,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account